Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Microbiota diversity, as we are ...

Graft-versus-host disease (GVHD) is a complication that can develop after a bone marrow or stem cell transplant. It occurs when the donor’s immune cells mistakenly attack the tissue in the recipient’s ...

Editor's note: This article is part of the ASTCT Update blog. To read more from this blog, click here. For years now, transplant physicians have spoken different languages when referring to a matter ...

Risk of graft-vs.-host disease, an often-debilitating and sometimes-deadly bone marrow transplant complication, can be reduced by matching key immune genes in a transplant recipient and their donor.

Tacrolimus and cyclosporine A show similar efficacy in long-term survival and relapse reduction in AML post-transplant patients. No significant differences were found in leukemia-free survival, ...

Graft-versus-host disease (GVHD) is a common side effect in people who receive cells from a donor (allogeneic transplant). It occurs when the transplanted cells recognize the recipient’s tissues as ...

Jakafi plus Rezurock showed promise in treating graft-versus-host disease in patients who underwent undergone allogeneic hematopoietic cell transplantation. More than half of patients responded to ...

NEW ORLEANS -- A three-drug regimen should be the standard for graft-versus-host disease (GvHD) prophylaxis in blood cancer patients undergoing reduced-intensity conditioning allogeneic hematopoietic ...

If chronic graft-versus-host disease (GVHD) has put a damper on your sex life, youre not alone. Physical symptoms like skin rashes, dryness, and tightening, along with fatigue and guilt over lack of ...